Flourine-18 flourodeoxyglucose Positron Emission Tomography as a non-invasive test of disease activity in Takayasu's arteritis - A report of four cases

Autoimmunity Reviews

Volumn 9, Issue 7, 2010, Pages 503-506

  Vista, Evan Glenn S ^a   Santos Estrella, Paul V ^a   Lichauco, Juan Javier T ^a  

^a ST LUKE S MEDICAL CENTER   (Philippines)

Author keywords

Acute phase reactant; Angiography; Fluorine 18 flourodeoxyglucose; Positron Emission Tomography; Takayasu's arteritis; Tuberculosis

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CILOSTAZOL; CLOPIDOGREL; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TELMISARTAN; WARFARIN; ANTICOAGULANT AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; AORTA ARCH SYNDROME; ASTHMA; CASE REPORT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGING; NON INVASIVE PROCEDURE; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; STENOSIS, OCCLUSION AND OBSTRUCTION; TAKAYASU ARTERITIS; TUBERCULOSIS, PULMONARY;

ADULT; ANTICOAGULANTS; ASTHMA; CONSTRICTION, PATHOLOGIC; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; TAKAYASU ARTERITIS; TUBERCULOSIS, PULMONARY;

EID: 77951879237     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2010.02.010     Document Type: Review

References (10)

1. Kerr G.S. Takayasu's arteritis. Rheum Dis Clin North Am 21 (1995) 1041-10588
2. Arend WP, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. 1990; 33:1129-1132.
3. Hoffman G.S., and Ahmed A.E. Surrogate markers of disease activity in patients with Takayasu arteritis. Int J Cardiol 66 suppl 1 (1998) S191-S194
4. Kerr G.S., Hallahan H.S., Giordano J., Fauci L.R.Y., AS R.M., and Hoffman G.S. Takayasu arteritis. Ann Intern Med 120 (1994) 919-929
5. Hara M., Goodman P.C., and Leder R.A. FDG-PET finding in early phase Takayasu's arteritis. J Comput Assist Tomogr 23 (1999) 16-18
6. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahasi N., and Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
7. 18F-FDG PET in characterizing disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31 (2004) 627-634
8. Yamato M., Lecky J.W., Hiramatsu K., and Kohda E. Takayasu arteritis: radiographic and angiographic findings in 59 patients. Radiology 161 (1986) 329-334
9. Pajari R., Hekali P., and Harjola P.T. Treatment of Takayasu's arteritis: An analysis of 29 operated patients. Thorac Cardiovasc Surg 34 (1986) 176-181
10. Belhocine T., Blockmans D., Hustinx R., Vandevivere J., and Mortelmans L. Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data. Eur J Nucl Med Mol Imaging 30 9 (September 2003)